Launch of Public Health Studies in Guatemala, supported by the U.S. Centers for Disease Control and Prevention (CDC)

REF# 2019-23                                                                                                                                        October 22 2019

Today the U.S. Centers for Disease Control and Prevention (CDC), part of the U.S. Mission in Guatemala, supported the launch of public health studies to better understand, detect, and respond to disease threats in Guatemala. Examples of these disease threats include illnesses caused by fevers (known as acute febrile illnesses), as well as antimicrobial resistance. Antimicrobial resistance occurs when medicines (antibiotics) typically prescribed by doctors no longer cure an illness, because the germs (bacteria) have grown resistant to the treatment. These threats are a concern for Guatemala, and knowing more about them can help Guatemalans be healthier in the future.

On October 22, at the Hospital Regional de Occidente in Quetzaltenango, Ambassador Luis E. Arreaga, together with representatives of the governments of the United States and Guatemala, participated in the opening event to launch these important studies. CDC is working closely with the Guatemalan Ministry of Public Health and Social Assistance, Universidad del Valle de Guatemala, and Washington State University to carry out these efforts.

“I am encouraged to see that this important work that demonstrates the strong scientific collaboration between our countries is carried out in Guatemala. These studies will help to better understand disease threats and improve the health, safety, and security of the Guatemalan people and the region, as part of our commitment to strengthening global health security,” said Ambassador Arreaga.

CDC has worked in Guatemala since 1978, helping to strengthen its laboratories, public health surveillance systems, and public health workforce.